What is Avapritinib: Uses, Dosage, Side Effects and More

Avapritinib is a targeted cancer medication that blocks specific proteins helping certain tumors grow. This oral medicine works by targeting mutated proteins in gastrointestinal stromal tumors (GIST) and systemic mastocytosis, two rare but serious conditions. Think of it as a precision tool that helps stop cancer cells from multiplying by interfering with their growth signals.

What is Avapritinib?

Avapritinib belongs to a class of medicines called tyrosine kinase inhibitors. It's specifically designed to target and block abnormal proteins that fuel the growth of certain rare cancers. The medication comes as oral tablets that you take by mouth, making treatment more convenient than intravenous options.

This medication is considered a strong, targeted therapy rather than traditional chemotherapy. It works by zeroing in on specific genetic mutations that drive tumor growth, particularly the PDGFRA D842V mutation in GIST tumors. Your doctor will likely test your tumor tissue to confirm you have the right type of mutation before prescribing this medication.

What is Avapritinib Used For?

Avapritinib treats two main conditions: advanced gastrointestinal stromal tumors (GIST) and aggressive systemic mastocytosis. Both are rare cancers that can be challenging to treat with conventional therapies. Let me walk you through what each condition involves and how this medication helps.

For GIST, avapritinib is specifically approved for tumors that have spread or cannot be removed surgically and carry a particular genetic mutation called PDGFRA D842V. These tumors typically don't respond well to other targeted therapies, making avapritinib an important treatment option. GIST tumors usually develop in the stomach or small intestine and can cause symptoms like abdominal pain, bleeding, or a feeling of fullness.

The medication is also used for aggressive systemic mastocytosis, a condition where too many mast cells build up in your organs. This can cause a range of symptoms including skin problems, digestive issues, and bone pain. Avapritinib helps control the abnormal mast cell growth and can reduce these troublesome symptoms.

How Does Avapritinib Work?

Avapritinib works by blocking specific enzymes called tyrosine kinases that send growth signals to cancer cells. When these enzymes are mutated or overactive, they tell cancer cells to keep growing and dividing uncontrollably. By blocking these signals, avapritinib helps slow down or stop tumor growth.

This medication is considered a strong, targeted therapy because it's designed to hit very specific molecular targets. Unlike traditional chemotherapy that affects many types of cells, avapritinib focuses on the particular proteins driving your cancer. This targeted approach often means fewer side effects compared to conventional chemotherapy, though it still requires careful monitoring.

The medication typically starts working within a few weeks to months of treatment. Your doctor will use scans and blood tests to monitor how well the treatment is working and adjust your care plan accordingly.

How Should I Take Avapritinib?

Take avapritinib exactly as your doctor prescribes, usually once daily on an empty stomach. This means taking it at least one hour before eating or two hours after eating. Taking it with food can increase absorption too much, potentially leading to more side effects.

Swallow the tablets whole with a full glass of water. Don't crush, break, or chew them, as this can affect how the medication is absorbed. If you have trouble swallowing tablets, talk to your doctor about alternative options rather than trying to modify the tablets yourself.

Try to take your dose at the same time each day to maintain consistent levels in your bloodstream. Many people find it helpful to set a daily reminder or link it to a regular activity like brushing their teeth. If you need to take other medications, check with your doctor about timing, as some medicines can interact with avapritinib.

How Long Should I Take Avapritinib For?

You'll typically continue taking avapritinib as long as it's helping control your cancer and you're tolerating it well. Unlike some medications that you take for a specific duration, targeted cancer therapies like avapritinib are usually taken long-term. Your doctor will regularly monitor your response and adjust treatment as needed.

The length of treatment varies greatly from person to person, depending on how your cancer responds and what side effects you experience. Some people take it for months, while others may continue for years. Regular follow-up appointments and scans help your medical team determine the best approach for your situation.

Never stop taking avapritinib suddenly without talking to your doctor first, even if you're feeling better. Stopping treatment prematurely could allow your cancer to start growing again. If you're experiencing troublesome side effects, your doctor can often adjust your dose or provide supportive care rather than stopping treatment entirely.

What Are the Side Effects of Avapritinib?

Like all cancer medications, avapritinib can cause side effects, though not everyone experiences them. Understanding what to expect can help you recognize and manage any issues that arise. Most side effects are manageable with proper support and monitoring from your healthcare team.

The most common side effects tend to be manageable and often improve as your body adjusts to the medication:

• Nausea and vomiting, which can often be controlled with anti-nausea medications
• Diarrhea, typically mild to moderate and manageable with dietary changes
• Fatigue and weakness, which may improve with rest and gentle activity
• Swelling in your hands, feet, or around your eyes
• Hair color changes, particularly lightening or graying
• Decreased appetite, which your doctor can help address
• Abdominal pain or discomfort

These common side effects are usually mild to moderate and often become more manageable over time. Your healthcare team can provide strategies and medications to help minimize their impact on your daily life.

Some serious but less common side effects require immediate medical attention. While these are rare, it's important to be aware of them:

• Severe bleeding, including nosebleeds, bruising, or blood in stool or urine
• Heart problems, such as irregular heartbeat or shortness of breath
• Severe skin reactions, including rash, blistering, or peeling
• Signs of infection, like fever, chills, or persistent cough
• Severe diarrhea that doesn't improve with treatment
• Confusion or memory problems

If you experience any of these serious side effects, contact your doctor immediately or seek emergency medical care. Early intervention can often prevent complications and help you continue treatment safely.

Who Should Not Take Avapritinib?

Avapritinib isn't suitable for everyone, and your doctor will carefully evaluate whether it's right for you. Certain health conditions and situations may make this medication unsafe or less effective. Being honest about your medical history helps ensure you receive the safest treatment possible.

People with certain health conditions may need to avoid avapritinib or require special monitoring:

• Severe liver problems, as the medication is processed through the liver
• Serious heart conditions, including heart failure or irregular rhythms
• Active bleeding disorders or recent major bleeding episodes
• Pregnancy or breastfeeding, as it can harm developing babies
• Plans to become pregnant, as the medication can affect fertility
• Severe kidney disease requiring dialysis

Your doctor will also consider any medications you're currently taking, as some can interact with avapritinib. This includes prescription drugs, over-the-counter medications, and herbal supplements.

If you're planning surgery, dental work, or other medical procedures, let all your healthcare providers know you're taking avapritinib. The medication can affect bleeding and healing, so timing adjustments may be necessary.

Avapritinib Brand Names

Avapritinib is available under the brand name Ayvakit in the United States and other countries. This is the only brand name currently available, as the medication is relatively new and still under patent protection. You won't find generic versions of avapritinib yet.

When you pick up your prescription, make sure the pharmacy gives you Ayvakit specifically. If you have insurance coverage questions or need financial assistance, the manufacturer offers patient support programs that might help reduce your out-of-pocket costs.

Avapritinib Alternatives

Several other targeted therapies might be options if avapritinib isn't suitable for you or stops working effectively. The best alternative depends on your specific type of cancer, genetic mutations, and previous treatments. Your oncologist will help determine the most appropriate option for your situation.

For GIST tumors, alternatives might include imatinib (Gleevec), sunitinib (Sutent), or regorafenib (Stivarga). These medications work through similar mechanisms but target slightly different proteins. However, if your tumor has the PDGFRA D842V mutation, avapritinib may be your best option since other treatments often don't work well against this specific mutation.

For systemic mastocytosis, alternatives could include midostaurin (Rydapt) or other supportive treatments that help manage symptoms. Your doctor will consider factors like your overall health, previous treatments, and specific disease characteristics when recommending alternatives.

Is Avapritinib Better Than Imatinib?

Avapritinib and imatinib work better for different types of tumors, so one isn't universally better than the other. The choice depends on your specific genetic mutations and cancer type. Think of them as different keys designed for different locks - each works best for particular molecular targets.

For GIST tumors with the PDGFRA D842V mutation, avapritinib is typically more effective than imatinib. This particular mutation makes tumors resistant to imatinib, which is why avapritinib was specifically developed to overcome this resistance. Clinical studies show that avapritinib works better in these cases, with higher response rates and better tumor control.

However, imatinib remains the standard first-line treatment for most other types of GIST tumors. It has a longer track record, more predictable side effects, and is often better tolerated. Your doctor will test your tumor's genetic makeup to determine which medication is most likely to work for your specific situation.